Zoe E Betteridge

Summary

Affiliation: University of Bath
Country: UK

Publications

  1. pmc Novel autoantibodies and clinical phenotypes in adult and juvenile myositis
    Zoe E Betteridge
    Royal National Hospital for Rheumatic Diseases, NHS Foundation Trust, Upper Borough Walls, Bath, Somerset, BA1 1RL, UK
    Arthritis Res Ther 13:209. 2011
  2. doi request reprint Newly identified autoantibodies: relationship to idiopathic inflammatory myopathy subsets and pathogenesis
    Harsha Gunawardena
    Department of Rheumatology, Royal National Hospital for Rheumatic Diseases, Bath Institute for Rheumatic Diseases and School for Health, University of Bath, Bath, UK
    Curr Opin Rheumatol 20:675-80. 2008
  3. doi request reprint Myositis-specific autoantibodies: their clinical and pathogenic significance in disease expression
    Harsha Gunawardena
    Department of Rheumatology, Royal National Hospital for Rheumatic Diseases, Bath, UK
    Rheumatology (Oxford) 48:607-12. 2009

Collaborators

  • Harsha Gunawardena
  • Neil J McHugh

Detail Information

Publications3

  1. pmc Novel autoantibodies and clinical phenotypes in adult and juvenile myositis
    Zoe E Betteridge
    Royal National Hospital for Rheumatic Diseases, NHS Foundation Trust, Upper Borough Walls, Bath, Somerset, BA1 1RL, UK
    Arthritis Res Ther 13:209. 2011
    ....
  2. doi request reprint Newly identified autoantibodies: relationship to idiopathic inflammatory myopathy subsets and pathogenesis
    Harsha Gunawardena
    Department of Rheumatology, Royal National Hospital for Rheumatic Diseases, Bath Institute for Rheumatic Diseases and School for Health, University of Bath, Bath, UK
    Curr Opin Rheumatol 20:675-80. 2008
    ..This review highlights the recent work on novel myositis-specific autoantibodies, their autoantigen targets, the relationship to clinical subsets and potential role in pathogenesis...
  3. doi request reprint Myositis-specific autoantibodies: their clinical and pathogenic significance in disease expression
    Harsha Gunawardena
    Department of Rheumatology, Royal National Hospital for Rheumatic Diseases, Bath, UK
    Rheumatology (Oxford) 48:607-12. 2009
    ..In this review, we discuss the clinical utility and pathogenic significance of MSAs in disease expression...